Department of Neuroscience and Behavior, Faculty of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Acta Psychiatr Scand. 2010 Mar;121(3):216-26. doi: 10.1111/j.1600-0447.2009.01459.x. Epub 2009 Aug 19.
To assess the rate of comorbidities and the functional impairment associated with the social anxiety disorder (SAD), with an emphasis on the so-called subthreshold clinical signs and symptoms.
Psychiatric comorbidities and psychosocial functioning were evaluated in 355 volunteers (college students) who had been diagnosed as SAD (n = 141), Subthreshold SAD (n = 92) or Controls (n = 122).
The rate of comorbidities was 71.6% in the SAD group and 50% in subjects with Subthreshold SAD, both significantly greater than Controls (28.7%). Concerning psychosocial functioning, the SAD group had higher impairment than the other two groups in all domains evaluated, and subjects with Subthreshold SAD presented intermediate values.
The rates of psychiatric comorbidities and the impairment of psychosocial functioning increase progressively along the spectrum of social anxiety. The fact that Subthreshold SAD causes considerable disability and suffering in comparison with control subjects justifies a review of the validity of the diagnostic criteria.
评估社交焦虑障碍(SAD)相关的共病率和功能损害,重点关注所谓的亚临床体征和症状。
对 355 名志愿者(大学生)进行了精神病共病和心理社会功能评估,这些志愿者被诊断为 SAD(n=141)、亚临床 SAD(n=92)或对照组(n=122)。
SAD 组的共病率为 71.6%,亚临床 SAD 组为 50%,均显著高于对照组(28.7%)。在心理社会功能方面,SAD 组在所有评估领域的损害均高于其他两组,而亚临床 SAD 组则呈现出中间值。
随着社交焦虑谱系的进展,精神共病率和心理社会功能损害的发生率呈递增趋势。与对照组相比,亚临床 SAD 导致相当大的残疾和痛苦,这证明了对诊断标准有效性的重新审视是合理的。